Completed PHASE4 INTERVENTIONAL 2-arm NCT04086186

Adductor Canal Block Versus Liposomal Bupivacaine in TKA

Clinical Outcomes of an Adductor Canal Block Versus Liposomal Bupivacaine in Total Knee Arthroplasty Patients: A Randomized Prospective Study

Sponsor: Good Samaritan Regional Medical Center, Oregon

Conditions Post-operative Pain Control Total Knee Arthroplasty

Interventions Adductor canal block Liposomal Bupivacaine Peri-articular Injection

Updated 4 times since 2019 Last updated: Sep 9, 2019 Started: Mar 22, 2017 Primary completion: Nov 25, 2018 Completion: Dec 18, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Post-operative Pain Control and Total Knee Arthroplasty and is currently completed. Good Samaritan Regional Medical Center, Oregon leads this study, which shows 4 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Oct 2019 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Good Samaritan Regional Medical Center, Oregon

Data source: Good Samaritan Regional Medical Center, Oregon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Corvallis, United States